MTNB
Matinas Biopharma·AMEX
--
--(--)
--
--(--)
3.52 / 10
Netural
Technically, MTNB scores 3.52/10 with a neutral rating. The pattern set is mixed: Long Upper Shadow (6.55) hints at bullish pressure, while Long Lower Shadow (3.02) and MACD Death Cross (1.00) lean bearish. Recent five-day data show two bearish and one neutral indicator dominating, reflecting market indecision. Traders may wait for clearer trend confirmation before initiating positions, as current signals do not strongly favor either side.
Analysis Checks(1/3)
Long Lower Shadow
Score3.02/10
Win Rate45.98%
Hist. Signals87
Avg Return1.24%
Score3.02/10
Win Rate45.98%
Hist. Signals87
Avg Return1.24%
MACD Death Cross
Score1/10
Win Rate22.22%
Hist. Signals9
Avg Return-1.46%
Score1/10
Win Rate22.22%
Hist. Signals9
Avg Return-1.46%
Long Upper Shadow
Score6.55/10
Win Rate56.00%
Hist. Signals100
Avg Return1.30%
Score6.55/10
Win Rate56.00%
Hist. Signals100
Avg Return1.30%
Long Lower Shadow
Score3.02/10
Win Rate45.98%
Hist. Signals87
Avg Return1.24%
Score3.02/10
Win Rate45.98%
Hist. Signals87
Avg Return1.24%
Long Upper Shadow
Score6.55/10
Win Rate56.00%
Hist. Signals100
Avg Return1.30%
Score6.55/10
Win Rate56.00%
Hist. Signals100
Avg Return1.30%
MACD Death Cross
Score1/10
Win Rate22.22%
Hist. Signals9
Avg Return-1.46%
Score1/10
Win Rate22.22%
Hist. Signals9
Avg Return-1.46%
Technical Analysis of MTNB?
- MTNB presents a Netural setup with a Technical Score of 3.52/10. Key technical indicators highlight an RSI of 42.43 and a MACD of -0.01, with the trend anchored by the 50-Day SMA at 0.69. Traders should monitor key support at 0.54 and resistance at 0.64.
